Bio-Techne (TECH) Gains from Investment Securities (2009 - 2026)
Bio-Techne's quarterly Gains from Investment Securities came in at $700000.0 in Q1 2026, down 12.5% year-on-year from $800000.0 in Q1 2025, and up 240.0% quarter-over-quarter from -$500000.0 in Q4 2025.
Bio-Techne has reported Gains from Investment Securities for 18 years, with the latest figure at $700000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities fell 12.5% year-over-year to $700000.0; the trailing twelve-month figure through Mar 2026 stood at -$28.5 million (down 3662.5% YoY), and the FY2025 full-year result was $1.8 million, up 71.98% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $700000.0, up from -$500000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $5.0 million in Q3 2024, with the low at -$54.7 million in Q2 2024.
- Average Gains from Investment Securities over 5 years is -$4.9 million, with a median of $800000.0 recorded in 2023.
- Peak annual rise in Gains from Investment Securities reached 666.67% in 2022, while the deepest fall reached 2262.64% in 2022.
- Tracing TECH's Gains from Investment Securities over 5 years: stood at $2.3 million in 2022, then sank by 43.48% to $1.3 million in 2023, then slipped by 23.08% to $1.0 million in 2024, then slumped by 150.0% to -$500000.0 in 2025, then soared by 240.0% to $700000.0 in 2026.
- The last three Gains from Investment Securities figures came in at $700000.0 (Q1 2026), -$500000.0 (Q4 2025), and $500000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 700,000.00 |
| Mar 31, 2026 | 700,000.00 |
| Dec 31, 2025 | -500,000.00 |
| Dec 31, 2025 | -500,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | -29.20 Mn |
| Jun 30, 2025 | -29.20 Mn |
| Mar 31, 2025 | 800,000.00 |
| Mar 31, 2025 | 800,000.00 |
| Dec 31, 2024 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 4.98 Mn |
| Sep 30, 2024 | 4.98 Mn |
| Jun 30, 2024 | -54.70 Mn |
| Jun 30, 2024 | -54.70 Mn |
| Mar 31, 2024 | 1.90 Mn |
| Mar 31, 2024 | 1.90 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 800,000.00 |
| Sep 30, 2023 | 800,000.00 |
| Jun 30, 2023 | -16.55 Mn |
| Jun 30, 2023 | -16.55 Mn |
| Mar 31, 2023 | 2.30 Mn |
| Mar 31, 2023 | 2.30 Mn |
| Dec 31, 2022 | 2.30 Mn |
| Dec 31, 2022 | 2.30 Mn |
| Sep 30, 2022 | 2.30 Mn |
| Sep 30, 2022 | 2.30 Mn |
| Jun 30, 2022 | -4.30 Mn |
| Jun 30, 2022 | -4.30 Mn |
| Mar 31, 2022 | 3.40 Mn |
| Mar 31, 2022 | 3.40 Mn |
| Dec 31, 2021 | 25.00 Mn |
| Dec 31, 2021 | 25.00 Mn |
| Sep 30, 2021 | 300,000.00 |
| Sep 30, 2021 | 300,000.00 |
| Jun 30, 2021 | -182,000.00 |
| Jun 30, 2021 | -182,000.00 |
| Mar 31, 2021 | 700,000.00 |
| Mar 31, 2021 | 700,000.00 |
| Dec 31, 2020 | 700,000.00 |
| Dec 31, 2020 | 700,000.00 |
| Sep 30, 2020 | 700,000.00 |
| Sep 30, 2020 | 700,000.00 |
| Jun 30, 2020 | -44.73 Mn |
| Jun 30, 2020 | -44.73 Mn |
| Mar 31, 2020 | 800,000.00 |
| Mar 31, 2020 | 800,000.00 |
| Dec 31, 2019 | 700,000.00 |
| Dec 31, 2019 | 700,000.00 |
| Sep 30, 2019 | 11.60 Mn |
| Sep 30, 2019 | 11.60 Mn |
| Mar 31, 2019 | 900,000.00 |
| Mar 31, 2019 | 900,000.00 |
| Dec 31, 2018 | 900,000.00 |
| Dec 31, 2018 | 900,000.00 |
| Sep 30, 2018 | 14.90 Mn |
| Sep 30, 2018 | 14.90 Mn |
| Jun 30, 2018 | -400,000.00 |
| Jun 30, 2018 | -400,000.00 |
| Mar 31, 2018 | 1.10 Mn |
| Mar 31, 2018 | 1.10 Mn |
| Dec 31, 2017 | 1.00 Mn |
| Dec 31, 2017 | 1.00 Mn |
| Sep 30, 2017 | 600,000.00 |
| Sep 30, 2017 | 600,000.00 |
| Jun 30, 2017 | 500,000.00 |
| Jun 30, 2017 | 500,000.00 |
| Mar 31, 2017 | 1.10 Mn |
| Mar 31, 2017 | 1.10 Mn |
| Dec 31, 2016 | 1.10 Mn |
| Dec 31, 2016 | 1.10 Mn |
| Sep 30, 2016 | 900,000.00 |
| Sep 30, 2016 | 900,000.00 |
| Jun 30, 2016 | 600,000.00 |
| Jun 30, 2016 | 600,000.00 |
| Mar 31, 2016 | 804,000.00 |
| Mar 31, 2016 | 804,000.00 |
| Dec 31, 2015 | 777,000.00 |
| Dec 31, 2015 | 777,000.00 |
| Sep 30, 2015 | 736,000.00 |
| Sep 30, 2015 | 736,000.00 |
| Jun 30, 2015 | 600,000.00 |
| Jun 30, 2015 | 600,000.00 |
| Mar 31, 2015 | 538,000.00 |
| Mar 31, 2015 | 538,000.00 |
| Dec 31, 2014 | 564,000.00 |
| Dec 31, 2014 | 564,000.00 |
| Sep 30, 2014 | 467,000.00 |
| Sep 30, 2014 | 467,000.00 |
| Jun 30, 2014 | 399,000.00 |
| Jun 30, 2014 | 399,000.00 |
| Mar 31, 2014 | 167,000.00 |
| Mar 31, 2014 | 167,000.00 |
| Dec 31, 2013 | 167,000.00 |
| Dec 31, 2013 | 167,000.00 |
| Sep 30, 2013 | 138,000.00 |
| Sep 30, 2013 | 138,000.00 |
| Jun 30, 2013 | 51.98 Mn |
| Jun 30, 2013 | 51.98 Mn |
| Mar 31, 2013 | -806,000.00 |
| Mar 31, 2013 | -806,000.00 |
| Dec 31, 2012 | 337,000.00 |
| Dec 31, 2012 | 337,000.00 |
| Sep 30, 2012 | 87,000.00 |
| Sep 30, 2012 | 87,000.00 |
| Jun 30, 2012 | -123,000.00 |
| Jun 30, 2012 | -123,000.00 |
| Mar 31, 2012 | 597,000.00 |
| Mar 31, 2012 | 597,000.00 |
| Dec 31, 2011 | -108,000.00 |
| Dec 31, 2011 | -108,000.00 |
| Jun 30, 2011 | 5,000.00 |
| Jun 30, 2011 | 5,000.00 |
| Mar 31, 2011 | -47,000.00 |
| Mar 31, 2011 | -47,000.00 |
| Dec 31, 2010 | -183,000.00 |
| Dec 31, 2010 | -183,000.00 |
| Jun 30, 2010 | -222,000.00 |
| Jun 30, 2010 | -222,000.00 |
| Mar 31, 2010 | -75,000.00 |
| Mar 31, 2010 | -75,000.00 |
| Dec 31, 2009 | 10,000.00 |
| Dec 31, 2009 | 10,000.00 |
| Sep 30, 2009 | 65,000.00 |
| Sep 30, 2009 | 65,000.00 |